IP Library Granted Patent US 10,584,153
Granted Patent B2
US 10,584,153 · App. 15/142,324 · Granted Mar 10, 2020

Treatment of damaged nerve with PTEN inhibitor

Inventors: Kwan Hee Lee (Rockville, MD); Moon Jong Noh (Rockville, MD); Kwangwook Ahn (Rockville, MD)
Assignee: Kolon TissueGene, Inc.
C07K14/4703C12N9/16C12Y301/03067A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,584,153
App. No.
15/142,324
Granted
Mar 10, 2020
Kind
B2
Abstract

The present application discloses a method of growing or proliferating nerve cells by contacting the cells with phosphatase and tensin homolog (PTEN) lipid phosphatase inhibiting peptide.

Claims (10)

1. A method of regenerating a nerve or attenuating degeneration of a nerve at a site of nerve injury comprising administering at or an area near an injured nerve, a nerve regenerating or nerve degeneration attenuating amount of phosphatase and tensin homolog (PTEN) lipid phosphatase inhibiting peptide of amino acid sequence of SEQ ID NOS:3 to 6.

2. The method according to claim 1 , wherein the peptide comprises a PDZ domain binding motif.

3. The method according to claim 1 , wherein the peptide further comprises a peptide transfer domain (PTD).

4. The method according to claim 1 , wherein the nerve injury is in the central nervous system.

5. A peptide which inhibits phosphatase and tensin homolog (PTEN) lipid phosphatase activity, wherein the peptide is a PTEN peptide of amino acid sequence of SEQ ID NOS:3 to 6.

6. The peptide according to claim 5 , wherein the peptide comprises a PDZ domain binding motif.

7. The peptide according to claim 5 , wherein the peptide further comprises a peptide transfer domain (PTD).

8. A method of growing, proliferating or enhancing cell activity of a nerve cell comprising contacting the nerve cell with a phosphatase and tensin homolog (PTEN) lipid phosphatase inhibiting peptide of amino acid sequence of SEQ ID NOS:3 to 6.

9. The peptide according to claim 8 , wherein the peptide comprises a PDZ domain binding motif.

10. The peptide according to claim 8 , wherein the peptide further comprises a peptide transfer domain (PTD).

Assignments (2)
CHANGE OF NAME Recorded Dec 3, 2018
From: TISSUEGENE, INC.
To: KOLON TISSUEGENE, INC.
Reel/Frame 047662/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2016
From: LEE, KWAN HEE; NOH, MOON JONG; AHN, KWANGWOOK
To: TISSUEGENE, INC.
Reel/Frame 038419/0703 →
Continuity (3)
Continuation PCTUS2014063900 · Nov 4, 2014
Provisional Application 61899795 · Nov 4, 2013
Related Publication 20160340396A1 · Nov 24, 2016